ArticleMolecular therapy. Methods & clinical development2014

Bioengineered coagulation factor VIII enables long-term correction of murine hemophilia A following liver-directed adeno-associated viral vector delivery.

Harrison C Brown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.